L1CAM-AS1 and lipoid nephrosis: Only one study, consisting of 6 patients (2 minimal change disease (MCD), 2 FSGS, 1 membranous nephropathy (MN), and 1 MN and FSGS), reported the efficacy of LCAP in primary kidney disease.